Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Dinner, Shira N
Associate Professor
Bio
Dr. Dinner is a clinical researcher with an interest in novel molecularly targeted therapies for leukemias, in particular acute lymphoblastic leukemia (ALL). Development of future clinical t... [more]